Triangle-Based Healthcare Communications Agencies Merge
Partnership of MicroMass Communications, Inc., and Strategic Pharma Solutions, Inc., to Offer Expanded Capabilities, Enhanced Solutions for Clients
CARY, NC (January 7, 2016) – MicroMass Communications, Inc., a Cary-based healthcare communications agency, and Strategic Pharma Solutions, Inc. (SPS), a Raleigh-based healthcare communications agency, announced today that the two companies have merged.
With 85 employees and 25 active clients across the US and worldwide, the unified, full-service company will be one of the largest healthcare communications agencies in the Southeast. The new company will operate as MicroMass Communications, Inc., at the existing MicroMass location in Cary, NC.
MicroMass will maintain a specialized focus with more comprehensive offerings to address the challenges in today’s healthcare environment. The company’s innovative solutions will drive behavior change and improve outcomes for healthcare and pharmaceutical industries.
“This was a unique opportunity to create a great partnership between two successful companies,” said Alyson Connor, president at MicroMass. “We plan on leveraging the strength of both agencies to provide new, integrative capabilities and services for our existing and future clients.”
With expertise in human health behavior, MicroMass builds marketing programs that are fundamentally different. Beyond traditional messaging and education, MicroMass uses evidence-based techniques from behavioral science and health psychology to engage patients in their health. The agency also delivers highly specialized services in key areas, including patient engagement and support, relationship marketing, and prelaunch scientific communications.
SPS tailors communications solutions for pharmaceutical, medical device, and biotechnology companies through its digital, scientific, and creative offerings. The agency also specializes in brand strategy and market development for oncology and rare disease products coming to market or currently on the market.
In 2014, Periscope Equity LLC, a private equity firm that helps successful companies accelerate innovation, made a significant investment in SPS to grow its digital offerings and expand market leadership.
“In this combined agency, we’ve created a dynamic team with a strong infrastructure and culture,” said Paul Bonavita, founder and board member of SPS. “It’s our goal to continue to distinguish ourselves and provide forward-thinking strategic solutions to address the needs of both patient and professional audiences.”
The leadership at MicroMass will remain the same. Connor will continue to serve as president, while Phil Stein will remain as chief executive officer. Periscope continues to invest in the merged company to accelerate innovation.
For more information about the merger between MicroMass Communications, Inc., and Strategic Pharma Solutions, Inc., please contact Chad Benditz, Marketing and PR Specialist for MicroMass Communications at 919.917.3325 or email@example.com.
About MicroMass Communications, Inc.
Founded in 1994, MicroMass is a healthcare communications agency with unique expertise in human health behavior. The agency’s mission is to deliver optimal health outcomes by helping patients with chronic conditions, cancer, or rare diseases build the confidence and the skills they need to better engage in their care. The agency’s innovative methods, grounded in health psychology, help clients in the pharmaceutical industry succeed in a value-based healthcare environment.
For more information, visit www.micromass.com.
About Strategic Pharma Solutions, Inc.
Founded in 2007, Strategic Pharma Solutions is a healthcare communications agency focused on bringing its clients tailor-made, strategic solutions for their marketing and communications needs through its digital, strategy, scientific, and creative offerings. SPS also provides pharmaceutical companies with data collection and management services to reach target audiences, including healthcare providers and key opinion leaders.
About Periscope Equity LLC
Periscope Equity LLC is a Chicago-based, lower-middle market, private equity firm focused exclusively on making significant investments in technology-enabled business services companies. Periscope targets companies with distinct paths of growth, differentiated service offerings, and strong cash flow generation. Providing financial capital, industry knowledge, and operational expertise, Periscope partners with proven management teams to grow businesses organically and through acquisitions.
For more information, visit www.periscopeequity.com.